Topic: Benzodiazepines

Dr. Peter Bregan’s research into the discovery process of lawsuits against Eli Lilly revealed that pharmaceutical companies suppressed data regarding dangerous side effects during SSRI trials. Approximately 38% of trial participants experienced a "stimulation effect," ranging from agitation to akathisia, a neurological condition that induces suicidal impulses. To hide these effects from the FDA and outperform placebos, researchers administered benzodiazepines like Xanax to sedate trial participants.

Dr. Justin Feinstein explains his transition from traditional neuropsychology to studying flotation as a natural alternative to addictive pharmaceuticals like benzodiazepines and opioids. Data collected over a decade suggests that floating can reset the nervous system and provide a potent antidote to the stress of modern society. The research aims to establish flotation as a validated medical treatment for chronic pain and anxiety.

Annette recounts her 50-year history with anti-anxiety medications, beginning with a Librium prescription at age 18. She describes the difficulty of tapering off Effexor and the experience of "brain zaps" caused by serotonin fluctuations. The narrative highlights the transition from seeking psychological counseling to being placed on a long-term pharmaceutical "cocktail."